OncoBLAZE

?? Exciting Day for OncoBLAZE! ?? Today, OncoBLAZE had the privilege of participating in the ribbon-cutting ceremony for BlueSkyLabs, the cutting-edge startup space designed to empower innovative life sciences companies like ours. We're thrilled to call this incredible facility our home! The event was a showcase of inspiration, with encouraging messages from esteemed leaders, including Medical Univ. of South Carolina (MUSC) Chief Innovation Officer Dr. Jesse Goodwin, MUSC President Dr. David Cole, and Deputy Secretary of Commerce Ashley Teasdel, who emphasized the importance of fostering innovation in the region. A special highlight for our team was meeting Charleston Mayor William Cogswell Jr., a strong advocate for advancing technology and entrepreneurship in our city. Our CEO, Dr. Dieter Haemmerich, had the pleasure of connecting with Mayor Cogswell in person, a moment of great encouragement for our mission at OncoBLAZE. We are honored to be part of this vibrant community and are excited to keep pushing boundaries in cancer recurrence prevention and life sciences innovation. Here's to a bright future at Blue Sky Labs! ??? #Innovation #LifeSciences #OncoBLAZE #BlueSkyLabs #CancerPrevention #Entrepreneurship #MUSC #SouthCharleston #RibbonCutting The picture shows from right to left: Mayor William Cogswell Jr, CIO Jesse Goodwin, and our CEO Dieter Haemmerich.

?? Innovative strides in cancer prevention! ?? We are thrilled to give a shout-out to OncoBLAZE LLC, a groundbreaking academic startup founded out of the Medical University of South Carolina and an Innosphere Ventures client company, that has secured a $374,000 NIH Phase I STTR Grant to advance its cutting-edge cancer recurrence prevention technology. ?? OncoBLAZE's technology uses precision laser-heated nanoparticles to target residual cancer cells and prevent recurrence. This funding supports preclinical studies, advancing this life-saving innovation toward human clinical trials. Congratulations to the OncoBLAZE team! ?? Learn more about this technology and impact: https://lnkd.in/giE-g4Xu #Innovation #CancerPrevention #LifeSciences #ZuckerInstitute #OncoBLAZE #MUSC

OncoBLAZE LLC,?an innovative academic startup founded out of the Medical University of South Carolina (MUSC)?and an?Innosphere client company, has been awarded a $374,000 Phase I Small Business Technology Transfer (STTR) grant by The National Institutes of Health (NIH). This is the second STTR Phase I grant the company has secured within its first year, having previously received a grant from the National Science Foundation (NSF) earlier in 2024. This new funding will enable OncoBLAZE to conduct preclinical studies in rodent tumor models, further validating its cutting-edge cancer recurrence prevention technology. Read the full release here: https://lnkd.in/giE-g4Xu

Join us at the #ZuckerInstitute Breakfast pitch to hear our CEO, Dieter Haemmerich, present OncoBLAZE's groundbreaking approach to Precision Cancer Therapy! Discover how we're advancing treatments to target and eliminate residual cancer cells, aiming to prevent recurrence and improve patient outcomes. Don't miss this opportunity to learn more about our mission to revolutionize cancer care! #OncoBLAZE #CancerTherapy #Innovation

?? Exciting News! ?? We are thrilled to announce that OncoBLAZE has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO), officially recognizing OncoBLAZE as our registered trademark! This milestone solidifies our commitment to pioneering innovative solutions in cancer recurrence prevention and our unique approach to drug-device combinations. A huge thank you to our entire team, partners, and supporters who have been pivotal in this journey. We’re excited to keep blazing new trails in healthcare and make a lasting impact on patients' lives. Stay tuned for more updates as we continue to push forward! #OncoBLAZE #CancerPrevention #USPTO #Trademark #HealthcareInnovation

We had an incredible experience at the Rocky Mountain Life Sciences Investor & Partnering Conference here in beautiful Breckenridge, Colorado! ?? At OncoBlaze, we were thrilled to connect with fellow incubator peers, investors, and strategic partners. The energy and innovation from over 30 companies presenting life-saving technologies were truly inspiring. A huge thank you to the CBSA team for highlighting the wealth of investment opportunities in Colorado, and to Siri Lindley for her powerful keynote on the importance of perseverance and the life-saving impact of clinical trials. We are more motivated than ever to continue driving forward with our mission to prevent cancer recurrence and contribute to the remarkable breakthroughs happening in the thriving life sciences community. Together, we are stronger. ?? #FightCancerRecurrence #StrongerTogether #COBioScience #COHubforHealthImpact https://lnkd.in/efjX_2wg

OncoBLAZE LLC, an innovative startup from the Medical University of South Carolina and Innosphere client company, has been awarded $275,000??Phase I Small Business Technology Transfer (STTR) grant by the National Science Foundation (NSF). This grant will support the development of their groundbreaking precision chemotherapy delivery technology to prevent cancer recurrence after surgery. OncoBLAZE’s cutting-edge technology combines a thermo-sensitive liposomal drug with a precision heat source to eliminate the residual cancer cells left behind after surgical procedures. This innovative technique has the potential to drastically reduce the likelihood of cancer regrowth offering a potential cure to cancer patients who would otherwise face the risk of relapse. Full release here: https://lnkd.in/guMVvvjC

OncoBLAZE has been #awarded a Phase I STTR grant by the National Science Foundation (#NSF). This grant will support their groundbreaking research and development of technology for precision chemotherapy delivery. The company aims to address the unmet need of preventing cancer recurrence after surgery, which affects millions of people globally each year. By leveraging thermo-sensitive liposomal nanoparticle drugs and precision heat sources, OncoBLAZE seeks to eliminate residual cancer cells post-surgery. This innovative approach has the potential to significantly limit the likelihood of cancer recurrence, and cure cancer patients who otherwise would require additional therapies that are less likely curative.?This grant will enable OncoBLAZE to advance their successful preclinical studies with their patent-pending technology and represents a significant step forward in the fight against cancer recurrence. The anticipated outcome is a game-changing therapy that offers a cure to cancer patients who would otherwise experience cancer regrowth. #OncoBLAZE #NSF #CancerResearch #Funding

We're #hiring a new Research And Development Engineer in Charleston, South Carolina Metropolitan Area. Apply today or share this post with your network.

?? OncoBLAZE is now a South Carolina Research Association Member Company ?? We are thrilled to share that OncoBLAZE has officially become a member company of the prestigious South Carolina Research Association (#SCRA)! At OncoBLAZE, we are committed to pushing the boundaries of cancer research and technology to improve patient outcomes. Joining SCRA as a member company represents a significant milestone in our journey toward making a tangible difference in the fight against cancer. As a member of SCRA, we gain access to a wealth of resources, expertise, and collaborative opportunities that will further empower us to drive innovation and make meaningful advancements in cancer care. We are incredibly grateful for this opportunity and excited to contribute to the vibrant ecosystem of research and innovation in South Carolina. Thank you to SCRA for welcoming us into this esteemed community. Together, we will continue to push the boundaries of what's possible in cancer research and make a lasting impact on the lives of patients and their families. Stay tuned for more updates as we embark on this exciting new chapter! #OncoBLAZE #SCRA #CancerResearch #InnovationInSC